好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2023 Fall Conference | L3 - Turning Conflict into Collaboration: Using Neuroscience for Programs and Organizations to Thrive

Friday 10/27/23
01:00 PM - 02:30 PM PDT Add To Calendar
This program will be presented in-person only
This program is not expected to be available in the meeting's On Demand product.
Seminar
Ezgi Tiryaki, MD, FAAN
Leadership
Participants should learn about a common stumbling block to working in teams: conflict. Participants should learn about a neuroscience-based tool to work through, rather than avoid, conflict. The SCARF model involves five domains of human social experience: Status, Certainty, Autonomy, Relatedness and Fairness. Status is about relative importance to others. Certainty is about the ability to predict the future. Autonomy provides a sense of control. Relatedness is a sense of safety with others. Fairness is a perception of fair exchanges between people. Participants should be able to apply a neuroscience-based model to organizational conflict, reflect on procedures and practices that trigger a threat response in organizations, and develop action steps that help reduce social threat and maximize rewards for improved organizational leadership. 
 
This program is supported in part by an educational grant from Alnylam Pharmaceuticals, Inc.
The Academy was solely responsible, with no influence from the industry supporter, for selection of content, format, presenters, and moderators of this CME program, and the speakers have not been contacted or influenced in any way by the industry supporter with regard to this CME program.
1.50 CME credits
Interpersonal and Communication Skills, Professionalism
Fellow, Resident, Other, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator
Case-based, Interactive, Audience Participation, Small Group

Program Materials

Event Timeline
01:00 PM - 01:10 PM PDT Introduction Introduction & Icebreaker
Jeffrey C. McClean II, MD, FAAN
01:10 PM - 01:20 PM PDT Speaker Introduction to SCARF
Ezgi Tiryaki, MD, FAAN
01:20 PM - 01:30 PM PDT Discussion Organization Level Case Study
Jeffrey C. McClean II, MD, FAAN
01:30 PM - 02:05 PM PDT Discussion Case Study Group Activity
Ezgi Tiryaki, MD, FAAN
02:05 PM - 02:25 PM PDT Discussion Discussion & Group Debrief
Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN
02:25 PM - 02:30 PM PDT Speaker Summary & Closing Remarks
Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN
Faculty Disclosures
Ezgi Tiryaki, MD, FAAN Dr. Tiryaki has stock in HITIT Leadership Coaching. Dr. Tiryaki has a non-compensated relationship as a Professor of Neurology with University of Minnesota that is relevant to AAN interests or activities. Dr. Tiryaki has a non-compensated relationship as a Clinic Director of a Center of Excellence with The ALS Association that is relevant to AAN interests or activities.
Jeffrey C. McClean II, MD, FAAN Dr. McClean has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. McClean has received personal compensation in the range of $0-$499 for serving as a Committee Member with 好色先生.
Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN Dr. De Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurology Academy. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. De Luca has received research support from NIHR, BRC (Oxford). The institution of Dr. De Luca has received research support from National Health and Medical Research (Australia). The institution of Dr. De Luca has received research support from UK MS Society. The institution of Dr. De Luca has received research support from Oxford-Quinnipiac Partnership. The institution of Dr. De Luca has received research support from US Department of Defense. The institution of Dr. De Luca has received research support from Wellcome ISSF (Oxford). The institution of Dr. De Luca has received research support from Bristol Myers Squibb. The institution of Dr. De Luca has received research support from University of Oxford (John Fell Fund). The institution of Dr. De Luca has received research support from National Health and Medical Research (Australia). Dr. De Luca has a non-compensated relationship as a Editorial board member with MS Journal that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Vice-Chair of Grant Review Panel with UK MS Society that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Steering Group member with MS Academy that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Board of Directors with SEQUINS that is relevant to AAN interests or activities.